Decellularized scaffolds in regenerative medicine

Yaling Yu; Ali Alkhawaji; Yuqiang Ding; Jin Mei

doi:10.18632/oncotarget.10945

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Decellularized scaffolds in regenerative medicine

Yaling Yu, Ali Alkhawaji, Yuqiang Ding and Jin Mei _

PDF | HTML | How to cite

Oncotarget. 2016; 7:58671-58683. https://doi.org/10.18632/oncotarget.10945

Metrics: PDF 3436 views | HTML 4111 views | ?

Abstract

Yaling Yu1,2, Ali Alkhawaji3, Yuqiang Ding4 and Jin Mei1,2,4

1 Department of Anatomy, Wenzhou Medical University, Wenzhou, China

2 Institute of Bioscaffold Transplantation and Immunology, Wenzhou Medical University, Wenzhou, China

3 Department of Anatomy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

4 Institute of Neuroscience, Wenzhou Medical University, Wenzhou, China

Correspondence to:

Jin Mei, email:

Keywords: decellularized scaffold, extracellular matrix, regeneration, organ, in vivo/in vitro

Received: February 24, 2016 Accepted: July 18, 2016 Published: July 29, 2016

Abstract

Allogeneic organ transplantation remains the ultimate solution for end-stage organ failure. Yet, the clinical application is limited by the shortage of donor organs and the need for lifelong immunosuppression, highlighting the importance of developing effective therapeutic strategies. In the field of regenerative medicine, various regenerative technologies have lately been developed using various biomaterials to address these limitations. Decellularized scaffolds, derived mainly from various non-autologous organs, have been proved a regenerative capability in vivo and in vitro and become an emerging treatment approach. However, this regenerative capability varies between scaffolds as a result of the diversity of anatomical structure and cellular composition of organs used for decellularization. Herein, recent advances in scaffolds based on organ regeneration in vivo and in vitro are highlighted along with aspects where further investigations and analyses are needed.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10945

Publication Alerts

Reviews:

Decellularized scaffolds in regenerative medicine

Abstract